GlassScriptPhysician profile
Theodore L Vander Velde
NPI 1417967068
$2,898.82
in general payments reported to CMS, 2019-2025
11 companies · $864 in 2025
The $864 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.97 · 2020: $25.85 · 2022: $300 · 2023: $731 · 2024: $891 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.50 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $763.22 | 2022-2025 | Star Tumor Ablation System, Stabilit, Stabilit System |
| Bard Peripheral Vascular, INC. | $399.08 | 2023-2024 | Trek |
| Siemens Medical Solutions USA, INC. | $319.95 | 2023-2025 | Varian Cryocare Touch System, Intelliblate Microwave Ablation System Console |
| Stryker Corporation | $291.23 | 2019-2022 | |
| Galvanize Therapeutics, INC | $282.65 | 2023-2024 | Aliya System |
| Boston Scientific Corporation | $261.81 | 2024 | Intracept |
| Bone Support INC. | $236.25 | 2024 | Cerament G, Ceramentbone Void Filler |
| Amgen INC. | $139.95 | 2025 | Evenity |
| Illuminoss Medical, INC. | $128.62 | 2025 | |
| Penumbra, INC. | $60.19 | 2024 | Indigo System |
| Becton, Dickinson and Company | $15.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Vander Velde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.